$28.40 +0.90 (%) Medicines Co - NASDAQ

Jan. 23, 2015 | 04:00 PM

Partner Headlines

  1. Catalysts To Watch For In RBC Capital's 2015 Top Small-Cap Biotechs

    Benzinga | Jan. 22, 2015 | 12:27PM EST
  2. Benzinga's Top Upgrades

    Benzinga | Jan. 21, 2015 | 08:47AM EST
  3. Biotechs Presenting At The J.P. Morgan Healthcare Conference: Day 1

    Benzinga | Jan. 12, 2015 | 08:55AM EST
  4. What Investors Should Expect From Rockwell Medical's Next FDA Decision

    Benzinga | Jan. 7, 2015 | 16:22PM EST
  5. Mid-Morning Market Update: Markets Surge; Monsanto Profit Tops Estimates

    Benzinga | Jan. 7, 2015 | 10:59AM EST
  6. Morning Market Losers

    Benzinga | Jan. 7, 2015 | 09:50AM EST
  7. Tuesday's After-Hours Movers

    Benzinga | Jan. 6, 2015 | 17:10PM EST
  8. The Medicines Company Surges Amid Credit Suisse Upgrade

    Benzinga | Nov. 20, 2014 | 10:16AM EST
  9. US Stock Futures Surge Ahead Of Earnings, ADP Data

    Benzinga | Nov. 5, 2014 | 07:18AM EST
  10. The Medicines Company Announces First Patient Enrollment In Phase 3 Studies Of CARBAVANCE in Development For The Treatment Of Serious Bacterial Infections Due To Gram-Negative Bacteria

    Benzinga | Nov. 5, 2014 | 06:36AM EST
  11. Midday Gainers From October 28: Buffalo Wild Wings, Integrated Device Technology, Cliffs Natural Resources And More

    Benzinga | Oct. 28, 2014 | 13:22PM EST
  12. Morning Market Movers

    Benzinga | Oct. 28, 2014 | 09:48AM EST
  13. Bank Of America Q3 Small & Mid-Cap Biotech Preview

    Benzinga | Oct. 20, 2014 | 16:58PM EST
  14. BACTIVTM Phase 3 SOLO II Trial Results Published In The Journal Clinical Infectious Diseases

    Benzinga | Oct. 9, 2014 | 16:53PM EST
  15. Actavis Expands Antibiotics Presence With Durata Buy

    IBD | Oct. 6, 2014 | 10:58AM EST
  16. Conferences/Events Scheduled for Week of Jun. 9th to Jun. 13th

    Benzinga | Jun. 10, 2014 | 11:04AM EST
  17. Benzinga's Top Downgrades

    Benzinga | Apr. 17, 2014 | 08:02AM EST
  18. Benzinga's Top Downgrades

    Benzinga | Apr. 2, 2014 | 08:03AM EST
  19. Medicines Co.

    IBD | Apr. 1, 2014 | 18:53PM EST
  20. Mid-Afternoon Market Update: Compuware Holds Onto Gains, Clearwire Remains Down

    Benzinga | Apr. 1, 2014 | 16:00PM EST
  21. Stocks Higher In Afternoon; Thor Industires Jumps

    IBD | Apr. 1, 2014 | 13:40PM EST
  22. Mid-Day Market Update: Verint Shares Jump On Upbeat Results; Medicines Co. Falls

    Benzinga | Apr. 1, 2014 | 12:39PM EST
  23. Medicines Co. Down On Setback In Hospira Patent Case

    IBD | Apr. 1, 2014 | 12:12PM EST
  24. Stocks Hitting 52-Week Lows

    Benzinga | Apr. 1, 2014 | 10:30AM EST
  25. Mid-Morning Market Update: Markets Gain; Ford March Sales Rise 3%

    Benzinga | Apr. 1, 2014 | 10:28AM EST
  26. Morning Market Losers

    Benzinga | Apr. 1, 2014 | 09:53AM EST
  27. Benzinga's Top #PreMarket Losers

    Benzinga | Apr. 1, 2014 | 08:21AM EST
  28. Medicines Co. earnings miss

    IBD | Feb. 19, 2014 | 18:54PM EST
  29. Earnings Scheduled For February 19, 2014

    Benzinga | Feb. 19, 2014 | 04:30AM EST
  30. FDA nixes Medicines' drug

    IBD | Feb. 13, 2014 | 18:33PM EST
  31. Mid-Afternoon Market Update: Market Rally Levels Out As Time Warner/Comcast Deal Holds The Spotlight

    Benzinga | Feb. 13, 2014 | 15:48PM EST
  32. Mid-Day Market Update: U.S. Stocks Rise; Orbitz Shares Surge On Upbeat Results

    Benzinga | Feb. 13, 2014 | 12:44PM EST
  33. Medicines Co. Downgraded After FDA Panel Rejects Drug

    IBD | Feb. 13, 2014 | 12:38PM EST
  34. Mid-Morning Market Update: Markets Drop; Comcast To Acquire Time Warner Cable For $45.2B

    Benzinga | Feb. 13, 2014 | 10:25AM EST
  35. Stocks Hitting 52-Week Lows

    Benzinga | Feb. 13, 2014 | 10:14AM EST
  36. UPDATE: Credit Suisse Downgrades The Medicines Company Following Negative Cangrelor Panel

    Benzinga | Feb. 13, 2014 | 08:38AM EST
  37. Benzinga's Top #PreMarket Losers

    Benzinga | Feb. 13, 2014 | 08:18AM EST
  38. UPDATE: The Medicines Co. Reminds Investors of FDA CRDAC Meeting Today, Says Proposing Cangrelor Be Indicated to Maintain P2Y12 Inhibition

    Benzinga | Feb. 12, 2014 | 07:07AM EST
  39. Mid-Afternoon Market Update: Red Robin Continues to Rally as The Medicines Company Drops

    Benzinga | Feb. 10, 2014 | 16:16PM EST
  40. Leaders Hold Near Buy Points Despite Monday Sell-Off

    IBD | Jan. 14, 2014 | 16:31PM EST
  41. Biotech Stocks Back On Top, Led By Biogen, Alexion

    IBD | Jan. 13, 2014 | 18:07PM EST
  42. Scanning Leading Stocks For Earnings Growth In 2014

    IBD | Dec. 18, 2013 | 18:00PM EST
  43. Top 4 Mid-Cap Stocks In The Drug Manufacturers-Other Industry With The Lowest PEG Ratio

    Benzinga | Dec. 10, 2013 | 04:08AM EST
  44. Medicines acquires Rempex

    IBD | Dec. 4, 2013 | 18:36PM EST
  45. Benzinga's M&A Chatter for Wednesday December 4, 2013

    Benzinga | Dec. 4, 2013 | 17:21PM EST
  46. Medicines Co. Acquires Rempex Pharma; Street Applauds

    IBD | Dec. 4, 2013 | 11:21AM EST
  47. US Stock Futures Edge Higher Ahead Of ADP Report

    Benzinga | Dec. 4, 2013 | 07:12AM EST
  48. Five Medical Stocks Leaders Trade Near New Highs

    IBD | Nov. 22, 2013 | 18:49PM EST
  49. A Few Stocks Form Bases, But Have Flaws

    IBD | Nov. 20, 2013 | 18:30PM EST
  50. Strong Pipeline Expected To Drive Growth At Medicines Co.

    IBD | Nov. 15, 2013 | 18:30PM EST
Trading Center